Take Solutions Ltd

Take Solutions Ltd

₹ 28.6 -3.06%
26 Feb - close price
About

Founded in 2001 as a software services provider, TAKE is currently a technology driven, full service Clinical Research Organization. It helps biopharma companies throughout the drug development process, and beyond. Headquartered in Chennai, India, it has a global footprint spanning the Americas, Europe and the Asia Pacific region.
The co. delivers domain-intensive services in Life Sciences.
TAKE is the only full-service technology-driven Clinical Research Organization listed in India.
It has 1,70,000 regulatory submissions and submitted 5% of all regulatory submissions to USFDA 2012 to 2020.[1] [1] [2] [3]

Key Points

Services Offering
Life Sciences: The Company offers clients a unique combination of full-service Clinical Research, Generics Development, Data Sciences, Regulatory Affairs, and Pharmacovigilance/Safety services backed by distinctive technology expertise. [1]

  • Market Cap 422 Cr.
  • Current Price 28.6
  • High / Low 35.8 / 12.7
  • Stock P/E 118
  • Book Value 20.4
  • Dividend Yield 0.00 %
  • ROCE 3.58 %
  • ROE 2.88 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of -29.2% over last 3 years.
  • Earnings include an other income of Rs.2.55 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
0.18 1.52 5.20 4.02 11.68 9.00 12.75 16.78 12.75 14.79 5.42 0.00 0.00
4.84 2.45 3.33 3.03 12.46 12.56 15.22 14.27 13.46 12.08 4.41 1.08 1.51
Operating Profit -4.66 -0.93 1.87 0.99 -0.78 -3.56 -2.47 2.51 -0.71 2.71 1.01 -1.08 -1.51
OPM % -2,588.89% -61.18% 35.96% 24.63% -6.68% -39.56% -19.37% 14.96% -5.57% 18.32% 18.63%
16.17 -0.83 1.73 0.18 0.65 -474.38 1.24 -0.13 1.24 2.05 -0.34 0.13 0.71
Interest 0.09 0.08 0.08 0.07 0.07 0.06 0.06 0.05 0.04 0.47 0.21 0.19 0.17
Depreciation 0.39 0.39 0.36 0.29 0.29 0.29 0.29 0.28 0.28 0.28 0.30 0.30 0.11
Profit before tax 11.03 -2.23 3.16 0.81 -0.49 -478.29 -1.58 2.05 0.21 4.01 0.16 -1.44 -1.08
Tax % 0.63% 44.39% -7.91% -11.11% -2.04% -0.56% 0.00% 19.02% 66.67% -2.74% 112.50% 24.31% -331.48%
10.97 -1.24 3.41 0.91 -0.50 -480.98 -1.58 1.66 0.08 4.12 -0.02 -1.10 -4.65
EPS in Rs 0.74 -0.08 0.23 0.06 -0.03 -32.51 -0.11 0.11 0.01 0.28 -0.00 -0.07 -0.31
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
38.41 29.52 26.02 25.89 23.57 18.84 2.44 21.96 2.47 10.72 18.00 56.23 20.21
25.44 -6.98 22.37 24.45 18.36 22.44 18.64 35.83 19.38 17.59 31.35 53.35 19.08
Operating Profit 12.97 36.50 3.65 1.44 5.21 -3.60 -16.20 -13.87 -16.91 -6.87 -13.35 2.88 1.13
OPM % 33.77% 123.64% 14.03% 5.56% 22.10% -19.11% -663.93% -63.16% -684.62% -64.09% -74.17% 5.12% 5.59%
38.21 10.51 22.19 12.80 15.64 22.05 32.81 34.35 26.08 15.32 -459.92 3.61 2.55
Interest 7.96 4.13 2.41 0.11 0.40 3.08 1.07 0.17 0.49 0.36 0.30 0.68 1.04
Depreciation 4.53 4.59 5.38 0.74 0.19 0.80 0.80 0.80 1.74 1.57 1.23 1.11 0.99
Profit before tax 38.69 38.29 18.05 13.39 20.26 14.57 14.74 19.51 6.94 6.52 -474.80 4.70 1.65
Tax % 9.36% 4.31% 5.21% 15.46% 10.02% 1.10% -3.39% 10.81% -11.38% -19.63% -0.50% 8.72%
35.07 36.64 17.11 11.32 18.23 14.42 15.25 17.40 7.74 7.79 -477.17 4.29 -1.65
EPS in Rs 2.87 2.99 1.40 0.92 1.49 1.08 1.03 1.18 0.52 0.53 -32.26 0.29 -0.10
Dividend Payout % 34.22% 32.75% 70.13% 106.01% 65.88% 92.37% 155.17% 85.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 7%
5 Years: 87%
3 Years: 183%
TTM: -61%
Compounded Profit Growth
10 Years: -19%
5 Years: -11%
3 Years: 4%
TTM: 161%
Stock Price CAGR
10 Years: -2%
5 Years: -26%
3 Years: -21%
1 Year: 58%
Return on Equity
10 Years: -7%
5 Years: -14%
3 Years: -29%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 12.00 12.00 12.00 12.00 12.01 13.32 14.79 14.79 14.79 14.79 14.79 14.79 14.79
Reserves 279.90 305.02 308.07 304.24 306.70 504.69 754.74 747.66 751.03 760.28 283.65 287.98 286.75
36.47 11.03 0.00 0.00 72.77 0.00 0.00 0.00 3.85 0.00 2.39 1.82 1.78
38.78 22.09 11.29 8.80 22.35 16.03 7.15 11.81 6.62 11.20 10.94 14.11 7.65
Total Liabilities 367.15 350.14 331.36 325.04 413.83 534.04 776.68 774.26 776.29 786.27 311.77 318.70 310.97
12.00 7.43 2.05 0.63 0.48 4.60 3.86 3.07 5.97 4.43 3.24 2.12 1.55
CWIP 0.00 0.00 0.00 0.00 2.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 260.38 260.37 284.38 234.38 330.39 359.92 413.87 511.72 517.32 516.78 154.68 242.56 242.94
94.77 82.34 44.93 90.03 80.80 169.52 358.95 259.47 253.00 265.06 153.85 74.02 66.48
Total Assets 367.15 350.14 331.36 325.04 413.83 534.04 776.68 774.26 776.29 786.27 311.77 318.70 310.97

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
141.75 48.89 36.98 -2.55 -10.77 -32.96 -24.02 12.91 -14.91 -2.66 32.58 26.89
-123.36 4.89 -18.69 55.39 -91.88 -23.57 -87.92 -111.90 21.79 13.42 -40.19 -22.37
-21.72 -51.94 -23.00 -11.96 60.53 57.88 239.40 -28.45 -8.26 -0.25 -1.11 -0.84
Net Cash Flow -3.33 1.84 -4.71 40.87 -42.12 1.36 127.46 -127.44 -1.38 10.51 -8.72 3.69

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 41.81 80.86 36.33 42.58 57.76 61.61 136.13 106.87 1,034.41 80.69 87.19 0.00
Inventory Days
Days Payable
Cash Conversion Cycle 41.81 80.86 36.33 42.58 57.76 61.61 136.13 106.87 1,034.41 80.69 87.19 0.00
Working Capital Days 225.59 434.98 302.86 394.32 395.20 1,958.48 26,942.68 3,456.03 34,088.34 7,838.99 1,863.93 251.21
ROCE % 14.42% 22.27% 6.31% 4.24% 4.40% 3.95% 2.44% 2.46% 0.97% -0.90% 0.50% 3.58%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41%
1.72% 1.61% 1.55% 1.38% 0.84% 0.75% 0.41% 0.13% 0.13% 0.13% 0.00% 0.00%
1.13% 0.27% 0.28% 0.28% 0.28% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
43.74% 44.71% 44.76% 44.93% 45.47% 45.80% 46.19% 46.44% 46.45% 46.46% 46.57% 46.59%
No. of Shareholders 66,29086,09989,98686,24790,96890,36388,46986,92483,95082,04581,18379,336

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls